Crohn Disease

16 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Gastroenteritis, Inflammatory Bowel Diseases

Treatments and conditions

Crohn Disease
Treatment and conditionWhere it standsTrials
ATG + CliniMACS® TCR α/β Reagent Kit and CliniMACS® CD19 System + Prednisone/Methylprenisolone + Total Body Irradiation + RITUXIMAB + CLOFARABINE + Melphalan + PALIFERMIN for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AZD7798 for crohn diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bezlotoxumab for crohn diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brivekimig for crohn diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fluconazole for crohn diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Guselkumab for crohn diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
H021 Enteric-coated Tablets High-dose Group for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
H021 Enteric-coated Tablets Low-dose Group for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Infliximab for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
infliximab (IFX) infusion; azathioprine (AZA) caps for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
infliximab (IFX) placebo infusion; azathioprine (AZA) caps for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Intermittent Reduced Calorie Diet (IRCD) for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
local co-administration of autologous ADIpose for crohn diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for crohn diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Risankizumab for crohn diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vedolizumab for crohn diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.